One of the most significant initiatives undertaken by Merck to help improve access to medicines in developing countries is the Merck MECTIZAN® Donation Program. Established more than 20 years ago, the MECTIZAN Donation Program is longest-running disease-specific drug donation program and public/private partnership of its kind in history, and is widely regarded as one of the most successful public/private health collaborations in the world.
The content on this page was last modified on September 15, 2009.
Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.